Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors-Reference-Cited by-同舟云学术

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors

Published:2019-05-01 Issue:5 Volume:179 Page:713
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

San-Juan-Rodriguez Alvaro¹,Prokopovich Max V.¹²,Shrank William H.²,Good Chester B.²,Hernandez Inmaculada¹

Affiliation:

1. Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania

2. Insurance Services Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

http:///jamainternalmedicine/article-pdf/179/5/713/17551155/jamainternal_sanjuanrodriguez_2019_ld_180071.pdf

Reference5 articles.

1. Golimumab.;Mazumdar;MAbs,2009

2. Certolizumab pegol.;Goel;MAbs,2010

3. Prescribing patterns of intravenous golimumab for rheumatoid arthritis.;Brady;Clin Ther,2015

4. First Databank. AnalySource premier drug pricing services. https://www.fdbhealth.com/solutions/analysource-premier-drug-pricing-services/. Accessed April 13, 2018.

5. Centers for Medicare & Medicaid Services. 2017 Annual report of the board of trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/Downloads/TR2017.pdf. Accessed May 7, 2018.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors;Journal of Managed Care & Specialty Pharmacy;2021-01

2. Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy;Journal of Gastrointestinal Surgery;2020-11-02

3. The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders;Pediatric Drugs;2020-04-30

4. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018;JAMA;2020-03-03

5. Decomposition Analysis of Spending and Price Trends for Biologic Antirheumatic Drugs in Medicare and Medicaid;Arthritis & Rheumatology;2020-01-06